{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:05:49Z","timestamp":1789477549251,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kildare Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer is a major cause of mortality after solid organ transplantation (SOT). Quantifying this risk is difficult due to heterogeneous reports and methodological limitations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a population-based cohort study linking data between the UK Transplant Registry, National Cancer Registry, Civil Registration of Deaths, and Hospital Episode Statistics for all SOT recipients in England between 1st June 1992 and 31st December 2015.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Among 50,762 SOT recipients, 22,361 deaths were recorded, of which 3550 (15.9%) were due to cancer, making it the second leading cause of mortality. Overall cancer (excluding non-melanomatous skin cancer) standardised mortality ratio (SMR) was 2.12 (95% CI: 2.05\u20132.19). Cancer mortality was highest among lung recipients (SMR 3.49; 95% CI: 2.96\u20134.06), and lowest in kidney recipients (SMR 2.00; 95% CI: 1.92\u20132.08). Non-Hodgkin\u2019s Lymphoma had highest mortality after SOT (SMR 9.86; 95% CI: 9.01\u201310.75) and was elevated across all transplant types. However, liver and kidney cancer mortality was disproportionately elevated among liver (SMR: 9.30; 95% CI: 7.53\u201311.24) and kidney transplant recipients (SMR: 5.11; 95% CI: 4.34\u20135.93), respectively. Several cancers showed no increased mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>De novo cancer remains a major cause of long-term mortality after SOT in England, with risk stratified by cancer and\/or allograft.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-026-03529-4","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:41:55Z","timestamp":1782877315000},"page":"1086-1093","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["De novo cancer-related mortality after solid organ transplantation in England: the EpCOT study"],"prefix":"10.1038","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7677-3813","authenticated-orcid":false,"given":"Charlotte","family":"Stephens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7328-0467","authenticated-orcid":false,"given":"Raoul","family":"Reulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"3529_CR1","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1056\/NEJMon043418","volume":"351","author":"MH Sayegh","year":"2004","unstructured":"Sayegh MH, Carpenter CB. Transplantation 50 years later-progress, challenges, and promises. N Engl J Med. 2004;351:2761\u20136.","journal-title":"N Engl J Med"},{"key":"3529_CR2","unstructured":"Transplantation GOoDa. Total Transplants sum (Global) 2024 [Available from: www.transplant-observatory.org\/data-charts-and-tables\/chart."},{"key":"3529_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1848068","volume":"9","author":"Z Huo","year":"2020","unstructured":"Huo Z, Li C, Xu X, Ge F, Wang R, Wen Y, et al. Cancer risks in solid organ transplant recipients: results from a comprehensive analysis of 72 cohort studies. OncoImmunology. 2020;9:1848068.","journal-title":"OncoImmunology"},{"key":"3529_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1080\/13696998.2022.2033050","volume":"25","author":"CN Graham","year":"2022","unstructured":"Graham CN, Watson C, Barlev A, Stevenson M, Dharnidharka VR. Mean lifetime survival estimates following solid organ transplantation in the US and UK. J Med Econ. 2022;25:230\u20137.","journal-title":"J Med Econ"},{"key":"3529_CR5","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/ki.2013.458","volume":"85","author":"D Farrugia","year":"2014","unstructured":"Farrugia D, Mahboob S, Cheshire J, Begaj I, Khosla S, Ray D, et al. Malignancy-related mortality following kidney transplantation is common. Kidney Int. 2014;85:1395\u2013403.","journal-title":"Kidney Int"},{"key":"3529_CR6","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/cam4.1367","volume":"7","author":"F Jackson-Spence","year":"2018","unstructured":"Jackson-Spence F, Gillott H, Tahir S, Nath J, Mytton J, Evison F, et al. Mortality risk after cancer diagnosis in kidney transplant recipients: the limitations of analyzing hospital administration data alone. Cancer Med. 2018;7:931\u20139.","journal-title":"Cancer Med"},{"key":"3529_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"S Jeong","year":"2020","unstructured":"Jeong S, Lee HS, Kong SG, Kim DJ, Lee S, Park M-J, et al. Incidence of malignancy and related mortality after kidney transplantation: a nationwide, population-based cohort study in Korea. Sci Rep. 2020;10:1.","journal-title":"Sci Rep"},{"key":"3529_CR8","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1002\/ijc.32585","volume":"146","author":"BM Rosales","year":"2020","unstructured":"Rosales BM, De La Mata N, Vajdic CM, Kelly PJ, Wyburn K, Webster AC. Cancer mortality in kidney transplant recipients: an Australian and New Zealand population-based cohort study, 1980\u20132013. Int J Cancer. 2020;146:2703\u201311.","journal-title":"Int J Cancer"},{"key":"3529_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ije\/dyz076","volume":"49","author":"KE Henson","year":"2020","unstructured":"Henson KE, Elliss-Brookes L, Coupland VH, Payne E, Vernon S, Rous B, et al. data resource profile: national cancer registration dataset in England. Int J Epidemiol. 2020;49:16.","journal-title":"Int J Epidemiol"},{"key":"3529_CR10","unstructured":"England N Cancer Registration Statistics, England, 2022 2024 [Available from: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/cancer-registration-statistics\/england-2022\/quality_methodology."},{"key":"3529_CR11","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2024.39.e59","volume":"39","author":"BK Jang","year":"2024","unstructured":"Jang BK. Is the prevalence of chronic hepatitis b really increasing in Korea? J Korean Med Sci. 2024;39:e59.","journal-title":"J Korean Med Sci"},{"key":"3529_CR12","unstructured":"Agency UHS Hepatitis B in England 2024: Gov.UK; 2025 [Available from: https:\/\/www.gov.uk\/government\/publications\/hepatitis-b-in-england\/hepatitis-b-in-england-2024."},{"key":"3529_CR13","unstructured":"Observatory GO. Ranking (% obesity by country) 2022 [Available from: https:\/\/data.worldobesity.org\/rankings\/?age=a&sex=t."},{"key":"3529_CR14","unstructured":"Review WP Smoking Rates by Country 2025 2025 [Available from: https:\/\/worldpopulationreview.com\/country-rankings\/smoking-rates-by-country."},{"key":"3529_CR15","doi-asserted-by":"publisher","first-page":"e221229","DOI":"10.1001\/jamahealthforum.2022.1229","volume":"3","author":"RD Chow","year":"2022","unstructured":"Chow RD, Bradley EH, Gross CP. Comparison of cancer-related spending and mortality rates in the US vs 21 high-income countries. JAMA Health Forum. 2022;3:e221229.","journal-title":"JAMA Health Forum"},{"key":"3529_CR16","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/ijc.34787","volume":"154","author":"M Taborelli","year":"2024","unstructured":"Taborelli M, Serraino D, Cimaglia C, Furian L, Biancone L, Busnach G, et al. Cancer mortality after kidney transplantation: a multicenter cohort study in Italy. Int J Cancer. 2024;154:842\u201351.","journal-title":"Int J Cancer"},{"key":"3529_CR17","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/ijc.32299","volume":"146","author":"H Benoni","year":"2020","unstructured":"Benoni H, Eloranta S, Ekbom A, Wilczek H, Smedby KE. Survival among solid organ transplant recipients diagnosed with cancer compared to nontransplanted cancer patients\u2014A nationwide study. Int J Cancer. 2020;146:682\u201391.","journal-title":"Int J Cancer"},{"key":"3529_CR18","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1002\/cncr.32136","volume":"125","author":"AM Noone","year":"2019","unstructured":"Noone AM, Pfeiffer RM, Dorgan JF, Magder LS, Bromberg JS, Lynch CF, et al. Cancer-attributable mortality among solid organ transplant recipients in the United States: 1987 through 2014. Cancer. 2019;125:2647\u201355.","journal-title":"Cancer"},{"key":"3529_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMra1702693","volume":"378","author":"D Dierickx","year":"2018","unstructured":"Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med. 2018;378:549\u201362.","journal-title":"N Engl J Med"},{"key":"3529_CR20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","volume":"6","author":"A Humar","year":"2006","unstructured":"Humar A, Michaels M. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant. 2006;6:262\u201374.","journal-title":"Am J Transplant"},{"key":"3529_CR21","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1365-2141.2010.08161.x","volume":"149","author":"A Parker","year":"2010","unstructured":"Parker A, Bowles K, Bradley JA, Emery V, Featherstone C, Gupte G, et al. Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines. Br J Haematol. 2010;149:675\u201392.","journal-title":"Br J Haematol"},{"key":"3529_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/bju.15002","volume":"125","author":"O Bratt","year":"2020","unstructured":"Bratt O, Drevin L, Pr\u00fctz KG, Carlsson S, Wennberg L, Stattin P. Prostate cancer in kidney transplant recipients \u2013 a nationwide register study. BJU Int. 2020;125:679\u201385.","journal-title":"BJU Int"},{"key":"3529_CR23","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/ndt\/gfaa109","volume":"35","author":"SL Murray","year":"2020","unstructured":"Murray SL, O\u2019Leary E, De Bhail\u00eds \u00c1M, Deady S, Daly FE, O\u2019Kelly P, et al. Cancer survival in kidney transplant recipients in Ireland. Nephrol Dial Transplant. 2020;35:1802\u201310.","journal-title":"Nephrol Dial Transplant"},{"key":"3529_CR24","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/ijc.33934","volume":"150","author":"TK Friman","year":"2022","unstructured":"Friman TK, J\u00e4\u00e4maa-Holmberg S, \u00c5berg F, Helanter\u00e4 I, Halme M, Pentik\u00e4inen MO, et al. Cancer risk and mortality after solid organ transplantation: a population-based 30-year cohort study in Finland. Int J Cancer. 2022;150:1779\u201391.","journal-title":"Int J Cancer"},{"key":"3529_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04878-5","volume":"22","author":"S Mehralivand","year":"2024","unstructured":"Mehralivand S, Thomas C, Puhr M, Claessens F, van de Merbel AF, Dubrovska A, et al. New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium. J Transl Med. 2024;22:71.","journal-title":"J Transl Med"},{"key":"3529_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/ije\/dyac124","volume":"52","author":"EL Watts","year":"2022","unstructured":"Watts EL, Perez-Cornago A, Fensom GK, Smith-Byrne K, Noor U, Andrews CD, et al. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis. Int J Epidemiol. 2022;52:71\u201386.","journal-title":"Int J Epidemiol"},{"key":"3529_CR27","doi-asserted-by":"publisher","first-page":"288","DOI":"10.5534\/wjmh.180040","volume":"37","author":"K Fujita","year":"2019","unstructured":"Fujita K, Nonomura N. Role of Androgen Receptor in Prostate Cancer: A Review. World J Mens Health. 2019;37:288\u201395.","journal-title":"World J Mens Health"},{"key":"3529_CR28","doi-asserted-by":"crossref","unstructured":"Sanguedolce F, Tedde A, Basile G, Di Bello F, Baboudjian M, Uleri A, et al. Prostate cancer outcomes in immunocompromised patients: a systematic review and meta-analysis. Eur Urol Oncol. 2025;8:1140\u201349.","DOI":"10.1016\/j.euo.2025.05.021"},{"key":"3529_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/ajt.13978","volume":"17","author":"SA Acuna","year":"2017","unstructured":"Acuna SA, Huang JW, Scott AL, Micic S, Daly C, Brezden-Masley C, et al. Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines. Am J Transplant. 2017;17:103\u201314.","journal-title":"Am J Transplant"},{"key":"3529_CR30","unstructured":"Transplant NBa. Annual Report on Liver Transplantation 2024\/2025. 2025."},{"key":"3529_CR31","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1007\/s12072-021-10214-6","volume":"15","author":"A Lundberg B\u00e5ve","year":"2021","unstructured":"Lundberg B\u00e5ve A, Bergquist A, Bottai M, Warnqvist A, von Seth E, Nordenvall C. Increased risk of cancer in patients with primary sclerosing cholangitis. Hepatol Int. 2021;15:1174\u201382.","journal-title":"Hepatol Int"},{"key":"3529_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","volume":"36","author":"A Bergquist","year":"2002","unstructured":"Bergquist A, Ekbom A, Olsson R, Kornfeldt D, L\u00f6\u00f6f L, Danielsson \u00c5, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol. 2002;36:321\u20137.","journal-title":"J Hepatol"},{"key":"3529_CR33","doi-asserted-by":"publisher","DOI":"10.1177\/2054358117698669","volume":"4","author":"CP Kovesdy","year":"2017","unstructured":"Kovesdy CP, Furth SL, Zoccali C. Obesity and kidney disease: hidden consequences of the epidemic. Can J Kidney Health Dis. 2017;4:2054358117698669.","journal-title":"Can J Kidney Health Dis"},{"key":"3529_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/cld.807","volume":"14","author":"JC Ahn","year":"2019","unstructured":"Ahn JC, Sundaram V. Obesity and liver decompensation. Clin Liver Dis. 2019;14:12\u20135.","journal-title":"Clin Liver Dis"},{"key":"3529_CR35","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer-viewpoint of the IARC Working Group. N Engl J Med. 2016;375:794\u20138.","journal-title":"N Engl J Med"},{"key":"3529_CR36","doi-asserted-by":"publisher","first-page":"e2343333","DOI":"10.1001\/jamanetworkopen.2023.43333","volume":"6","author":"T Lawler","year":"2023","unstructured":"Lawler T, Walts ZL, Steinwandel M, Lipworth L, Murff HJ, Zheng W, et al. Type 2 diabetes and colorectal cancer risk. JAMA Netw Open. 2023;6:e2343333.","journal-title":"JAMA Netw Open"},{"key":"3529_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cancers12123850","volume":"12","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Rajput A, Jin N, Wang J. Mechanisms of immunosuppression in colorectal cancer. Cancers. 2020;12:12.","journal-title":"Cancers"},{"key":"3529_CR38","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1111\/ajt.14272","volume":"17","author":"SA Acuna","year":"2017","unstructured":"Acuna SA, Sutradhar R, Camacho X, Daly C, Del Giudice ME, Kim SJ, et al. Uptake of cancer screening tests among recipients of solid organ transplantation. Am J Transplant. 2017;17:2434\u201343.","journal-title":"Am J Transplant"},{"key":"3529_CR39","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","volume":"127","author":"G Fattovich","year":"2004","unstructured":"Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127:S35\u201350.","journal-title":"Gastroenterology"},{"key":"3529_CR40","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1097\/TP.0000000000003762","volume":"106","author":"DO Dahle","year":"2022","unstructured":"Dahle DO, Skauby M, Langberg CW, Brabrand K, Wessel N, Midtvedt K. Renal cell carcinoma and kidney transplantation: a narrative review. Transplantation. 2022;106:e52\u2013e63.","journal-title":"Transplantation"},{"key":"3529_CR41","first-page":"2025","volume":"2024\/","author":"NBA Transplant","year":"2025","unstructured":"Transplant NBA. Annual report on lung transplantation. 2025;2024\/:2025.","journal-title":"Annual report on lung transplantation"},{"key":"3529_CR42","unstructured":"Recipients OPaTNaSRoT. OPTN\/SRTR 2023 Annual Data Report. 2023 2025."},{"key":"3529_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/MOT.0000000000000753","volume":"25","author":"S Bos","year":"2020","unstructured":"Bos S, Vos R, Van Raemdonck DE, Verleden GM. Survival in adult lung transplantation: where are we in 2020? Curr Opin Organ Transplant. 2020;25:268\u201373.","journal-title":"Curr Opin Organ Transplant"},{"key":"3529_CR44","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3390\/arm91050033","volume":"91","author":"R Diel","year":"2023","unstructured":"Diel R, Simon S, Gottlieb J. Chronic lung allograft dysfunction is associated with significant disability after lung transplantation-A burden of disease analysis in 1025 cases. Adv Respir Med. 2023;91:432\u201344.","journal-title":"Adv Respir Med"},{"key":"3529_CR45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5500\/wjt.v10.i5.104","volume":"10","author":"N Yoshiyasu","year":"2020","unstructured":"Yoshiyasu N, Sato M. Chronic lung allograft dysfunction post-lung transplantation: the era of bronchiolitis obliterans syndrome and restrictive allograft syndrome. World J Transplant. 2020;10:104\u201316.","journal-title":"World J Transplant"},{"key":"3529_CR46","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/ki.2013.176","volume":"84","author":"I Begaj","year":"2013","unstructured":"Begaj I, Khosla S, Ray D, Sharif A. Socioeconomic deprivation is independently associated with mortality post kidney transplantation. Kidney Int. 2013;84:803\u20139.","journal-title":"Kidney Int"},{"key":"3529_CR47","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1080\/0284186X.2022.2143278","volume":"61","author":"G Ammitzb\u00f8ll","year":"2022","unstructured":"Ammitzb\u00f8ll G, Levinsen AKG, Kj\u00e6r TK, Ebbestad FE, Horsb\u00f8l TA, Saltb\u00e6k L, et al. Socioeconomic inequality in cancer in the Nordic countries. A systematic review. Acta Oncologica. 2022;61:1317\u201331.","journal-title":"Acta Oncologica"},{"key":"3529_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09727-w","volume":"20","author":"RM Simpson","year":"2020","unstructured":"Simpson RM, Knowles E, O\u2019Cathain A. Health literacy levels of British adults: a cross-sectional survey using two domains of the Health Literacy Questionnaire (HLQ). BMC Public Health. 2020;20:1819.","journal-title":"BMC Public Health"},{"key":"3529_CR49","unstructured":"Statistics OfN. Adult smoking habits in the UK: 2023 2023 [updated 01\/10\/2024. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/healthandlifeexpectancies\/bulletins\/adultsmokinghabitsingreatbritain\/2023."},{"key":"3529_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1017\/S0007114514002621","volume":"113","author":"ER Maguire","year":"2015","unstructured":"Maguire ER, Monsivais P. Socio-economic dietary inequalities in UK adults: an updated picture of key food groups and nutrients from national surveillance data. Br J Nutr. 2015;113:181\u20139.","journal-title":"Br J Nutr"},{"key":"3529_CR51","unstructured":"Survey ALA. Physical Activity: Department for Digital, Culture, Media and Sport; 2024 [Available from: https:\/\/www.ethnicity-facts-figures.service.gov.uk\/health\/diet-and-exercise\/physical-activity\/latest\/#by-ethnicity-and-socio-economic-group."},{"key":"3529_CR52","unstructured":"British Heart Foundation. Socioeconomic inequalities in heart and circulatory diseases in England: an analysis. 2025. [Available from: https:\/\/www.bhf.org.uk\/-\/media\/files\/what-we-do\/our-research\/heart-statistics\/health-inequalities\/socioeconomic-inequalities-in-heart-and-circulatory-diseases-in-england.pdf]."},{"key":"3529_CR53","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s41416-022-01718-5","volume":"126","author":"C Delon","year":"2022","unstructured":"Delon C, Brown KF, Payne NWS, Kotrotsios Y, Vernon S, Shelton J. Differences in cancer incidence by broad ethnic group in England, 2013\u20132017. Br J Cancer. 2022;126:1765\u201373.","journal-title":"Br J Cancer"},{"key":"3529_CR54","doi-asserted-by":"publisher","first-page":"358","DOI":"10.21037\/tau-22-138","volume":"11","author":"L Wang","year":"2022","unstructured":"Wang L, Ma K, Yao Y, Yu L, Wu J, Zhao Q, et al. Carcinogenicity risk associated with tacrolimus use in kidney transplant recipients: a systematic review and meta-analysis. Transl Androl Urol. 2022;11:358\u201366.","journal-title":"Transl Androl Urol"},{"key":"3529_CR55","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.kint.2020.10.018","volume":"99","author":"CD Blosser","year":"2021","unstructured":"Blosser CD, Haber G, Engels EA. Changes in cancer incidence and outcomes among kidney transplant recipients in the United States over a thirty-year period. Kidney Int. 2021;99:1430\u20138.","journal-title":"Kidney Int"},{"key":"3529_CR56","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1111\/ajt.14238","volume":"17","author":"JC Krisl","year":"2017","unstructured":"Krisl JC, Doan VP. Chemotherapy and transplantation: the role of immunosuppression in malignancy and a review of antineoplastic agents in solid organ transplant recipients. Am J Transplant. 2017;17:1974\u201391.","journal-title":"Am J Transplant"},{"key":"3529_CR57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00403-017-1724-5","volume":"309","author":"V Barton","year":"2017","unstructured":"Barton V, Armeson K, Hampras S, Ferris LK, Visvanathan K, Rollison D, et al. Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review. Arch Dermatol Res. 2017;309:243\u201351.","journal-title":"Arch Dermatol Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03529-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03529-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03529-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:14:00Z","timestamp":1789474440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03529-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10,5]]}},"alternative-id":["3529"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03529-4","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}